Product approval information for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific IgE antibodies for any of the five grass species contained in this product. ORALAIR is approved for use in persons 10 through 65 years of age.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MuzcIFU
No comments:
Post a Comment